PPIB/Cyclophilin B Expression Associates with Tumor Progression and Unfavorable Survival in Patients with Pulmonary Adenocarcinoma

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2024 Mar 8

PMID 38455410

Authors

Ilseon Hwang

Joon Seon Song

Eunho Cho

Kwon-Ho Song

Sang Hyun Ra

Chang-Min Choi

Tae Woo Kim

Sung-Han Kim

Jeong Won Kim

Joon-Yong Chung

Affiliations

Soon will be listed here.

Abstract

Cyclophilin B (CypB), encoded by peptidylprolyl isomerase B (), is involved in cellular transcriptional regulation, immune responses, chemotaxis, and proliferation. Recent studies have shown that PPIB/CypB is associated with tumor progression and chemoresistance in various cancers. However, the clinicopathologic significance and mechanism of action of PPIB/CypB in non-small cell lung cancer (NSCLC) remain unclear. In this study, we used RNA in situ hybridization to examine PPIB expression in 431 NSCLC tissue microarrays consisting of 295 adenocarcinomas (ADCs) and 136 squamous cell carcinomas (SCCs). Additionally, Ki-67 expression was evaluated using immunohistochemistry. The role of PPIB/CypB was assessed in five human NSCLC cell lines. There was a significant correlation between PPIB/CypB expression and Ki-67 expression in ADC (Spearman correlation =0.374, <0.001) and a weak correlation in SCC (=0.229, =0.007). In ADCs, high PPIB expression (PPIB) was associated with lymph node metastasis (=0.023), advanced disease stage (=0.014), disease recurrence (=0.013), and patient mortality (=0.015). Meanwhile, high Ki-67 expression (Ki-67) was correlated with male sex, smoking history, high pT stage, lymph node metastasis, advanced stage, disease recurrence, and patient mortality in ADC (all <0.001). However, there was no association between either marker or clinicopathological factors, except for old age and PPIB (=0.038) in SCC. Survival analyses revealed that the combined expression of PPIB/Ki-67 was an independent prognosis factor for poor disease-free survival (HR 1.424, 95% CI 1.177-1.723, <0.001) and overall survival (HR 1.266, 95% CI 1.036-1.548, =0.021) in ADC, but not in SCC. Furthermore, PPIB/CypB promoted the proliferation, colony formation, and migration of NSCLC cells. We also observed the oncogenic properties of PPIB/CypB expression in human bronchial epithelial cells. In conclusion, PPIB/CypB contributes to tumor growth in NSCLC, and elevated PPIB/Ki-67 levels are linked to unfavorable survival, especially in ADC.

References

Liu J, Zuo Y, Qu G, Song X, Liu Z, Zhang T . CypB promotes cell proliferation and metastasis in endometrial carcinoma. BMC Cancer. 2021; 21(1):747. PMC: 8240271. DOI: 10.1186/s12885-021-08374-7. View

Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C . Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 1991; 138(4):867-73. PMC: 1886092. View

Lee J, Yoon A, Kalapurakal S, Ro J, Lee J, Tu N . Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor. J Clin Oncol. 1995; 13(8):1893-903. DOI: 10.1200/JCO.1995.13.8.1893. View

Price E, Zydowsky L, Jin M, Baker C, McKeon F, WALSH C . Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci U S A. 1991; 88(5):1903-7. PMC: 51134. DOI: 10.1073/pnas.88.5.1903. View

Heitman J, Cullen B . Cyclophilin B escorts the hepatitis C virus RNA polymerase: a viral achilles heel?. Mol Cell. 2005; 19(2):145-6. DOI: 10.1016/j.molcel.2005.07.001. View

Choi T, Nguyen M, Kim J, Jo Y, Jang M, Nguyen N . Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer. J Pathol. 2018; 246(1):115-126. DOI: 10.1002/path.5107. View

Ganti A, Klein A, Cotarla I, Seal B, Chou E . Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA Oncol. 2021; 7(12):1824-1832. PMC: 8532041. DOI: 10.1001/jamaoncol.2021.4932. View

Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B . Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 2003; 63(19):6478-87. View

Rami-Porta R, Asamura H, Travis W, Rusch V . Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2):138-155. DOI: 10.3322/caac.21390. View

10.

Kim Y, Jang M, Lim S, Won H, Yoon K, Park J . Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans. Hepatology. 2011; 54(5):1661-78. DOI: 10.1002/hep.24539. View

11.

Teng M, Huang J, Zhu Z, Li H, Shen J, Chen Q . Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer. Pathol Res Pract. 2019; 215(6):152417. DOI: 10.1016/j.prp.2019.04.009. View

12.

Warth A, Cortis J, Soltermann A, Meister M, Budczies J, Stenzinger A . Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br J Cancer. 2014; 111(6):1222-9. PMC: 4453847. DOI: 10.1038/bjc.2014.402. View

13.

Jeong K, Kim K, Kim H, Oh Y, Kim S, Jo Y . Hypoxia induces cyclophilin B through the activation of transcription factor 6 in gastric adenocarcinoma cells. Oncol Lett. 2015; 9(6):2854-2858. PMC: 4473699. DOI: 10.3892/ol.2015.3102. View

14.

Chirieac L . Ki-67 expression in pulmonary tumors. Transl Lung Cancer Res. 2016; 5(5):547-551. PMC: 5099507. DOI: 10.21037/tlcr.2016.10.13. View

15.

Li Z, Li F, Pan C, He Z, Pan X, Zhu Q . Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma. Lung Cancer. 2021; 154:69-75. DOI: 10.1016/j.lungcan.2021.02.009. View

16.

Hou S, Zhou S, Qin Z, Yang L, Han X, Yao S . Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma. Am J Pathol. 2017; 187(5):954-962. DOI: 10.1016/j.ajpath.2017.01.009. View

17.

Yun J, Kwon Y, Kim J, Lee G, Choi S, Kim H . Clinical impact of histologic type on survival and recurrence in patients with surgically resected stage II and III non-small cell lung cancer. Lung Cancer. 2022; 176:24-30. DOI: 10.1016/j.lungcan.2022.12.008. View

18.

Roge R, Nielsen S, Riber-Hansen R, Vyberg M . Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience. Appl Immunohistochem Mol Morphol. 2020; 29(2):99-104. DOI: 10.1097/PAI.0000000000000846. View

19.

Meng D, Li P, Xie M . Expression and role of cyclophilin B in stomach cancer. Genet Mol Res. 2015; 14(2):5346-54. DOI: 10.4238/2015.May.22.5. View

20.

Ram B, Ramakrishna G . Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition. Biochim Biophys Acta. 2014; 1843(11):2497-512. DOI: 10.1016/j.bbamcr.2014.06.020. View